Incidence of cardiovascular events among tildrakizumab-treated patients with moderate-to-severe plaque psoriasis: pooled data from three large randomised clinical trials.
R BissonnettePablo Fernandez-PenasL PuigA M MendelsohnS J RozzoA MenterPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2019)